CONTENTS
|
|
|
OVERVIEW
■ EXTERNAL
PAGE
LABORATORY
INVESTIGATIONS
■
ESTROGEN
AND SOY ISOFLAVONOIDS
■
VALPROIC
ACID
CLINICAL
INVESTIGATIONS
TUMOR
VARIANTS AND SUBGROUPS
■
DESMOPLASTIC
NODULAR MEDULLOBLASTOMA
■
MEDULLOBLASTOMA
WITH EXTENSIVE NODULARITY
TREATMENT
OPTIONS
■
ETOPOSIDE
■ RE-IRRADIATION
■
VINBLASTINE
|
|
|
Overview
|
|
|
Archer
TC, Mahoney EL, Pomeroy SL.
Medulloblastoma:
Molecular Classification-Based Personal Therapeutics.
Neurotherapeutics.
2017 Apr;14(2):265-273. doi: 10.1007/s13311-017-0526-y.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Collange
NZ, Brito Sde A, Campos RR, Santos EA, Botelho RV; Sociedade
Brasileira de Neurocirurgia.
Treatment
of medulloblastoma in children and adolescents.
Rev
Assoc Med Bras (1992). 2016 Jul;62(4):298-302. doi:
10.1590/1806-9282.62.04.298.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Collange
NZ, Brito Sde A, Campos RR, Santos EA, Botelho RV.
Treatment
of medulloblastoma in children and adolescents. (FAQ)
Rev
Assoc Med Bras (1992). 2016 Jul;62(4):297. doi:
10.1590/1806-9282.62.04.297.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Frappaz D, Faure-Conter C, Bonneville Levard A, Barritault M,
Meyronet D, Sunyach MP.
Medulloblastomas in adolescents
and adults - Can the pediatric experience be extrapolated?
Neurochirurgie. 2018 Dec 17. pii: S0028-3770(18)30361-8.
doi: 10.1016/j.neuchi.2018.10.007.
[Epub ahead of print]
Source
|
Similar
articles
|
|
|
|
Kumar V, Kumar V, McGuire T, Coulter DW, Sharp JG, Mahato RI.
Challenges and Recent Advances in Medulloblastoma
Therapy.
Trends Pharmacol Sci. 2017 Oct 20. pii:
S0165-6147(17)30181-5. doi: 10.1016/j.tips.2017.09.002. [Epub
ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Sengupta
S, Pomeranz Krummel D, Pomeroy S.
The
evolution of medulloblastoma therapy to personalized medicine.
F1000Res.
2017 Apr 13;6:490. doi: 10.12688/f1000research.10859.1.
eCollection 2017.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
RELAPSE
IN MEDULLOBLASTOMA
|
|
|
Massimino
M, Casanova M, Polastri D, Biassoni V, Modena P, Pecori E,
Schiavello E, De Pava MV, Indini A, Rampini P, Bauer D, Catania S,
Podda M, Gandola L.
Relapse
in medulloblastoma: what can be done after abandoning high-dose
chemotherapy? A mono-institutional experience.
Childs
Nerv Syst. 2013 Jul;29(7):1107-12. doi: 10.1007/s00381-013-2104-x.
Epub 2013 Apr 18.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
Laboratory
investigations
|
|
|
|
OVERVIEW
|
|
.
|
Nör C, Ramaswamy V.
Clinical and pre-clinical
utility of genomics in medulloblastoma.
Expert Rev
Neurother. 2018 Jul 26:1-15. doi: 10.1080/14737175.2018.1503536.
[Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Remke M, Ramaswamy V.
Infant medulloblastoma - learning
new lessons from old strata.
Nat Rev Clin Oncol. 2018
Jul 20. doi: 10.1038/s41571-018-0071-6. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
ESTROGEN
AND SOY ISOFLAVONOIDS
|
|
|
Belcher
SM, Burton CC, Cookman CJ, Kirby M, Miranda GL, Saeed FO, Wray KE.
Estrogen and soy
isoflavonoids decrease sensitivity of medulloblastoma and central
nervous system primitive neuroectodermal tumor cells to
chemotherapeutic cytotoxicity.
BMC
Pharmacol Toxicol. 2017 Sep 6;18(1):63. doi:
10.1186/s40360-017-0160-7.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
VALPROIC
ACID
|
|
.
|
Mascaro-Cordeiro B, Oliveira ID, Tesser-Gamba F, Pavon LF,
Saba-Silva N, Cavalheiro S, Dastoli P, Toledo SRC.
Valproic
acid treatment response in vitro is determined by TP53 status in
medulloblastoma.
Childs Nerv Syst. 2018 May 22. doi:
10.1007/s00381-018-3817-7. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
Clinical
investigations
|
|
|
|
OVERVIEW
|
|
|
Bautista F, Fioravantti V, de Rojas T, Carceller F, Madero L,
Lassaletta A, Moreno L.
Medulloblastoma in children and
adolescents: a systematic review of contemporary phase I and II
clinical trials and biology update.
Cancer Med. 2017 Oct
4. doi: 10.1002/cam4.1171. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
.
|
Lassaletta A.
Medulloblastoma in infants: the
never-ending challenge.
Lancet Oncol. 2018
Jun;19(6):720-721. doi: 10.1016/S1470-2045(18)30278-X. Epub 2018
May 16.
Comment
on: Robinson GW et al, Risk-adapted therapy for young children
with medulloblastoma (SJYC07): therapeutic and molecular outcomes
from a multicentre, phase 2 trial. Lancet Oncol. 2018
Jun;19(6):768-784.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
.
|
Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM,
Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR,
Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z,
Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T,
Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders
RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA.
Risk-adapted therapy for young children with
medulloblastoma (SJYC07): therapeutic and molecular outcomes from
a multicentre, phase 2 trial.
Lancet Oncol. 2018
Jun;19(6):768-784. doi: 10.1016/S1470-2045(18)30204-3. Epub 2018
May 16.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
CHEMOTHERAPY
|
|
|
Bonney
PA, Santucci JA, Maurer AJ, Sughrue ME, McNall-Knapp RY, Battiste
JD.
Dramatic
response to temozolomide, irinotecan, and bevacizumab for
recurrent medulloblastoma with widespread osseous metastases.
J
Clin Neurosci. 2016 Apr;26:161-3. doi: 10.1016/j.jocn.2015.10.022.
Epub 2016 Jan 14.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Esbenshade
AJ, Kocak M, Hershon L, Rousseau P, Decarie JC, Shaw S, Burger P,
Friedman HS, Gajjar A, Moghrabi A.
A
Phase II feasibility study of oral etoposide given concurrently
with radiotherapy followed by dose intensive adjuvant chemotherapy
for children with newly diagnosed high-risk medulloblastoma
(protocol POG 9631): A report from the Children's Oncology Group.
Pediatr
Blood Cancer. 2016 Dec 21. doi: 10.1002/pbc.26373. [Epub ahead of
print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Gupta
A, Kumar A, Abrari A, Patir R, Vaishya S.
Successful
Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate
with Minimal Toxicity in an Infant with Medulloblastoma in
Extremely Poor General Condition.
World
Neurosurg. 2016 Jul 20. pii: S1878-8750(16)30568-X. doi:
10.1016/j.wneu.2016.07.044. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Kann
BH, Lester-Coll NH, Park HS, Yeboa DN, Kelly JR, Baehring JM,
Becker KP, Yu JB, Bindra RS, Roberts KB.
Adjuvant
chemotherapy and overall survival in adult medulloblastoma.
Neuro
Oncol. 2016 Aug 18. pii: now150. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Lafay-Cousin
L, Smith A, Chi SN, Wells E, Madden J, Margol A, Ramaswamy V,
Finlay J, Taylor MD, Dhall G, Strother D, Kieran MW, Foreman NK,
Packer RJ, Bouffet E.
Clinical,
Pathological, and Molecular Characterization of Infant
Medulloblastomas Treated with Sequential High-Dose Chemotherapy.
Pediatr
Blood Cancer. 2016 Sep;63(9):1527-34. doi: 10.1002/pbc.26042. Epub
2016 May 4. Erratum
in:
Pediatr Blood Cancer. 2017 Apr;64(4).
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
RADIOTHERAPY
|
|
.
|
Chin AL, Moding EJ, Donaldson SS, Gibbs IC, Soltys SG, Hiniker SM,
Pollom EL.
Survival Impact of Postoperative Radiotherapy
Timing in Pediatric and Adolescent Medulloblastoma.
Neuro
Oncol. 2018 Jan 4. doi: 10.1093/neuonc/noy001. [Epub ahead of
print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Padovani L, Horan G, Ajithkumar T.
Radiotherapy Advances
in Paediatric Medulloblastoma Treatment.
Clin Oncol (R
Coll Radiol). 2019 Mar;31(3):171-181. doi:
10.1016/j.clon.2019.01.001. Epub 2019 Jan 14.
Source
| Full
text | Similar
articles
|
|
|
.
|
Padovani L, Chapon F, André N, Boucekine M, Geoffray A,
Bourdeau F, Masliah-Planchon J, Claude L, Huchet A, Laprie A,
Supiot S, Coche-Dequéant B, Kerr C, Alapetite C, Leseur J,
Nguyen T, Chapet S, Bernier V, Bondiau PY, Noel G, Habrand JL,
Bolle S, Doz F, Dufour C, Muracciole X, Carrie C.
Hippocampal
Sparing During Craniospinal Irradiation: What Did We Learn About
the Incidence of Perihippocampus Metastases?
Int J
Radiat Oncol Biol Phys. 2018 Mar 15;100(4):980-986. doi:
10.1016/j.ijrobp.2017.12.265. Epub 2017 Dec 21.
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Scobioala
S, Parfitt R, Matulat P, Kittel C, Ebrahimi F, Wolters H, Am
Zehnhoff-Dinnesen A, Eich HT.
Impact
of radiation technique, radiation fraction dose, and total
cisplatin dose on hearing : Retrospective analysis of
29 medulloblastoma patients.
Strahlenther
Onkol. 2017 Sep 8. doi: 10.1007/s00066-017-1205-y. [Epub ahead of
print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Tian S, Sudmeier LJ, Zhang C, Madden NA, Buchwald ZS, Shu HG,
Curran WJ, Eaton BR, Esiashvili N.
Reduced-volume
tumor-bed boost is not associated with inferior local control and
survival outcomes in high-risk medulloblastoma.
Pediatr
Blood Cancer. 2019 Oct 1:e28027. doi: 10.1002/pbc.28027. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
RADIO-CHEMOTHERAPY
|
|
|
Dagmar D, Proescholdt M, Reinert C, Pietsch T, Jones DTW, Pfister
SM, Hattingen E, Seidel C, Dirven L, Luerding R, Reijneveld J,
Warmuth-Metz M, Bonsanto M, Bremer M, Combs S, Rieken S,
Herrlinger U, Kuntze H, Mayer-Steinacker R, Moskopp D, Schneider
T, Beringer A, Schlegel U, Stummer W, Welker H, Weyerbrock A,
Paulsen F, Rutkowski S, Weller M, Wick W, Kortmann RD, Bogdahn U,
Hau P.
Multicenter pilot study of radio-chemotherapy as
first-line treatment for adults with medulloblastoma (NOA-07).
Neuro Oncol. 2017 Aug 21. doi: 10.1093/neuonc/nox155.
[Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
SURGERY
|
|
.
|
Goyal A, Cajigas I, Ibrahim GM, Brathwaite CD, Khatib Z, Niazi T,
Bhatia S, Ragheb J.
Surgical Treatment of Intramedullary
Spinal Metastasis in Medulloblastoma: Case Report and Review of
the Literature.
World Neurosurg. 2018 Oct;118:42-46.
doi: 10.1016/j.wneu.2018.06.250. Epub 2018 Jul 7.
Source
.
Similar
articles
|
|
|
REOPERATION
|
|
.
|
Patel P, Wallace D, Boop FA, Vaughn B, Robinson GW, Gajjar A,
Klimo P Jr.
Reoperation for Medulloblastoma Prior to
Adjuvant Therapy.
Neurosurgery. 2018 Apr 11. doi:
10.1093/neuros/nyy095. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
Recurrent
tumors
|
|
|
Cefalo
G, Massimino M, Ruggiero A, Barone G, Ridola V, Spreafico F,
Potepan P, Abate ME, Mascarin M, Garrè ML, Perilongo G,
Madon E, Colosimo C, Riccardi R.
Temozolomide
is an active agent in children with recurrent
medulloblastoma/primitive neuroectodermal tumor: an Italian
multi-institutional phase II trial.
Neuro
Oncol. 2014 May;16(5):748-53. doi: 10.1093/neuonc/not320. Epub
2014 Jan 30.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Kameda-Smith MM, Wang A, Abdulhadi N, Voth R, Sergeant A, Maharaj
A, Bakhshinyan D, Adile AA, Pai AM, Ajani O, Yarascavitch B,
Alyman MC, Duckworth J, Samaan MC, Farrokhyar F, Singh SK, Fleming
A; Pediatric Brain Tumour Study Group.
Salvage Therapy
for Childhood Medulloblastoma: A Single Center Experience.
Can J Neurol Sci. 2019 Jul;46(4):403-414. doi:
10.1017/cjn.2019.39.
Source
| Full
text | Similar
articles
|
|
|
RADIOTHERAPY
|
|
|
Burki
TK.
Postoperative
radiotherapy for paediatric medulloblastoma.
Lancet
Oncol. 2016 Sep;17(9):e381. doi: 10.1016/S1470-2045(16)30390-4.
Epub 2016 Aug 11.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Kann
BH, Park HS, Lester-Coll NH, Yeboa DN, Benitez V, Khan AJ, Bindra
RS, Marks AM, Roberts KB.
Postoperative
Radiotherapy Patterns of Care and Survival Implications for
Medulloblastoma in Young Children.
JAMA
Oncol. 2016 Aug 4. doi: 10.1001/jamaoncol.2016.2547. [Epub ahead
of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Lannering
B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino
M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L,
Björk-Eriksson T, Giralt J, Oldenburger F, Pietsch T,
Figarella-Branger D, Robson K, Forni M, Clifford SC, Warmuth-Metz
M, von Hoff K, Faldum A, Mosseri V, Kortmann R.
Hyperfractionated
versus conventional radiotherapy followed by chemotherapy in
standard-risk medulloblastoma: results from the randomized
multicenter HIT-SIOP PNET 4 trial.
J
Clin Oncol. 2012 Sep 10;30(26):3187-93. doi:
10.1200/JCO.2011.39.8719. Epub 2012 Jul 30.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
CHEMOTHERAPY
AND RADIOTHERAPY
|
|
|
Massimino
M, Cefalo G, Riva D, Biassoni V, Spreafico F, Pecori E, Poggi G,
Collini P, Pollo B, Valentini L, Potepan P, Seregni E, Casanova M,
Ferrari A, Luksch R, Polastri D, Terenziani M, Pallotti F, Clerici
CA, Schiavello E, Simonetti F, Meazza C, Catania S, Podda M,
Gandola L.
Long-term
results of combined preradiation chemotherapy and age-tailored
radiotherapy doses for childhood medulloblastoma.
J
Neurooncol. 2012 May;108(1):163-71. doi:
10.1007/s11060-012-0822-7. Epub 2012 Feb 16.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
GROWTH
HORMONE REPLACEMENT THERAPY
|
|
|
Indini
A, Schiavello E, Biassoni V, Bergamaschi L, Magni MC, Puma N,
Chiaravalli S, Pallotti F, Seregni E, Diletto B, Pecori E, Gandola
L, Poggi G, Massimino M.
Long-term
safety of growth hormone replacement therapy after childhood
medulloblastoma and PNET: it is time to set aside old concerns.
J
Neurooncol. 2017 Jan;131(2):349-357. doi:
10.1007/s11060-016-2306-7. Epub 2016 Oct 21.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
METASTATIC
MEDULLOBLASTOMA
|
|
|
von
Bueren AO, Kortmann RD, von Hoff K, Friedrich C, Mynarek M, Müller
K, Goschzik T, Zur Mühlen A, Gerber N, Warmuth-Metz M,
Soerensen N, Deinlein F, Benesch M, Zwiener I, Kwiecien R, Faldum
A, Bode U, Fleischhack G, Hovestadt V, Kool M, Jones D, Northcott
P, Kuehl J, Pfister S, Pietsch T, Rutkowski S.
Treatment
of Children and Adolescents With Metastatic Medulloblastoma and
Prognostic Relevance of Clinical and Biologic Parameters.
J
Clin Oncol. 2016 Dec;34(34):4151-4160. Epub 2016 Oct 31.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
MILAN
STRATEGY
|
|
|
Vivekanandan
S, Breene R, Ramanujachar R, Traunecker H, Pizer B, Gaze MN, Saran
F, Thorp N, English M, Wheeler K, Michalski A, Walker DA, Saunders
D, Cowie F, Cameron A, Picton S, Parashar D, Horan G, Williams MV.
Reply
to Comment on: The UK Experience of a Treatment Strategy for
Pediatric Metastatic Medulloblastoma Comprising Intensive
Induction Chemotherapy, Hyperfractionated Accelerated
Radiotherapy, and Response-Directed High-Dose Myeloablative
Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Pediatr
Blood Cancer. 2016 Jun;63(6):1125-6. doi: 10.1002/pbc.25946. Epub
2016 Feb 17.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Massimino
M, Spreafico F, Pignoli E, Gandola L.
Comment
on: The UK Experience of a Treatment Strategy for Pediatric
Metastatic Medulloblastoma Comprising Intensive Induction
Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and
Response Directed High-Dose Myeloablative Chemotherapy or
Maintenance Chemotherapy (Milan Strategy).
Pediatr
Blood Cancer. 2016 Jun;63(6):1123-4. doi: 10.1002/pbc.25901. Epub
2016 Jan 14.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Vivekanandan
S, Breene R, Ramanujachar R, Traunecker H, Pizer B, Gaze MN, Saran
F, Thorp N, English M, Wheeler KA, Michalski A, Walker DA,
Saunders D, Cowie F, Cameron A, Picton SV, Parashar D, Horan G,
Williams MV.
The
UK Experience of a Treatment Strategy for Pediatric Metastatic
Medulloblastoma Comprising Intensive Induction Chemotherapy,
Hyperfractionated Accelerated Radiotherapy and Response Directed
High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy
(Milan Strategy).
Pediatr
Blood Cancer. 2015 Dec;62(12):2132-9. doi: 10.1002/pbc.25663. Epub
2015 Aug 14.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
Gandola
L, Massimino M, Cefalo G, Solero C, Spreafico F, Pecori E, Riva D,
Collini P, Pignoli E, Giangaspero F, Luksch R, Berretta S, Poggi
G, Biassoni V, Ferrari A, Pollo B, Favre C, Sardi I, Terenziani M,
Fossati-Bellani F.
Hyperfractionated
accelerated radiotherapy in the Milan strategy for metastatic
medulloblastoma.
J
Clin Oncol. 2009 Feb 1;27(4):566-71. doi:
10.1200/JCO.2008.18.4176. Epub 2008 Dec 15.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
SONIC
HEDGEHOG INHIBITION
|
|
|
Kieran
MW, Chisholm J, Casanova M, Brandes AA, Aerts I, Bouffet E, Bailey
S, Leary S, MacDonald TJ, Mechinaud F, Cohen KJ, Riccardi R, Mason
W, Hargrave D, Kalambakas S, Deshpande P, Tai F, Hurh E, Geoerger
B.
Phase
I study of oral sonidegib (LDE225) in pediatric brain and solid
tumors and a phase II study in children and adults with relapsed
medulloblastoma.
Neuro
Oncol. 2017 Jun 9. doi: 10.1093/neuonc/nox109. [Epub ahead of
print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Li Y, Song Q, Day BW.
Phase I and phase II sonidegib and
vismodegib clinical trials for the treatment of paediatric and
adult MB patients: a systemic review and meta-analysis.
Acta
Neuropathol Commun. 2019 Jul 30;7(1):123. doi:
10.1186/s40478-019-0773-8.
Source
.
Similar
articles
|
|
|
|
Lou
E, Schomaker M, Wilson JD, Ahrens M, Dolan M, Nelson AC.
Complete
and sustained response of adult medulloblastoma to first-line
sonic hedgehog inhibition with vismodegib.
Cancer
Biol Ther. 2016 Aug 12:1-7. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
Desmoplastic
Nodular Medulloblastoma
|
|
|
AbdelBaki MS, Boué DR, Finlay JL, Kieran MW.
Desmoplastic
Nodular Medulloblastoma in Young Children: A Management Dilemma.
Neuro Oncol. 2017 Nov 15. doi: 10.1093/neuonc/nox222.
[Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
Medulloblastoma
with extensive nodularity
|
|
|
Aristizabal
P, Burns L, Rivera-Gomez R, Levy ML, Roberts W, Crawford JR.
Medulloblastoma
With Extensive Nodularity: Tailored Therapy in a Low-resource
Setting.
J
Pediatr Hematol Oncol. 2017 Mar 6. doi:
10.1097/MPH.0000000000000798. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
|
|
|
|
